Skip to main content
. 2019 Feb 8;14(2):e0211865. doi: 10.1371/journal.pone.0211865

Fig 11. APRIL/BLyS blockade did not decrease donor specific antibody in sensitized transplant groups.

Fig 11

(A) T (CD3+) (B) B (CD45+) lymphocyte flow cross match was performed as previously described.